6-Bromo-4-chloropyridin-3-ol, 250mg

N,N-dimethyl-L-prolinamide hydrochloride, 95.0%, 5g

4-Methoxypyrimidine-2-carboxylic acid, 95.0%, 100mg

Trimethyl 1,3,5-Benzenetricarboxylate>98.0%(GC)25g

(2R,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride, 98%, 250mg

[(2S,3R)-5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-3,4-DIHYDRO-2H-CHROMEN-3-YL] 3,4,5-TRIHYDROXYBENZOATE, 95%, 50mg

5-(Hydroxymethyl)-2-methoxybenzoic acid, 98%, 25mg

TRI-O-CRESYL PHOSPHATE, 97.0%, 5g

(1-Benzyl-piperidin-4-yl)-N-methyl-amine, 97.0%, 5g

Tetrafluorosuccinic acid, 98.0%, 1g

2-Cyclopropylmorpholine hydrochloride, 97%, 100mg

GC capillary column ROTI®Cap-5, 50 m, 0.32 mm, 0.10 µm, 1 Piece(s)

tert-Butyl 5-Iodopyridin-2-ylcarbamate, 97.0%, 250mg